Forbion et al. in $196m round for NewAmsterdam Pharma
Forbion, Morningside Ventures and Ascendant BioCapital have led a $196m series-A funding round for Dutch clinical-stage biotechnology company NewAmsterdam Pharma (NAP).
More on Early-stage
Point72 Ventures leads €20m round for Curb
Food startup was founded in 2020 and will use the funding to invest in technology and its expansion in Stockholm
EQT Ventures backs Lenus with €50m series-A funding
Round is the largest series-A round ever secured by a startup in Denmark, according to EQT Ventures
Novo Seeds, Ysios Capital lead €51m round for Adcendo
RA Capital Management, HealthCap and Gilde Healthcare also take part in the round for the biotech startup
Jolt, Tesi et. al in €30m round for Virta
With the funding, the Finnish company will seek to expand into Asia, which it said was one of the largest markets for EV charging alongside Europe and North America
Latest News
Ardian acquires NetCo from IK
IK's exit comes two years after it acquired a majority stake in the company via its IK Small Cap II Fund
Inflexion buys ANS
Inflexion took a minority stake in IT service UKFast in 2018, increasing this to a majority in 2020
Patient Square leads $145m round for Apollo Therapeutics
Biotech company will use the funding to advance its lead therapeutic programmes into clinical development
OTPP's Innovation Platform leads $138m round for Beamery
UK-based recruitment software platform Beamery has raised a $138m funding round led by Ontario Teachers' Pension Plan Board (OTPP) via its Teachers' Innovation Platform (TIP).